Farmigea

Farmigea is a long-established, privately-held Italian leader in ophthalmology with a dual business model. It develops and markets its own portfolio of ophthalmic products while also providing comprehensive CDMO services for sterile ophthalmic formulations. With nearly eight decades of experience, the company leverages its specialized manufacturing and R&D capabilities to address a wide range of eye diseases and partner with other entities in the sector. Its strategy combines proprietary innovation with contract services to capture value across the ophthalmic therapeutics and medical device market.

Specialized platform for the formulation and sterile manufacturing of all topical ophthalmic dosage forms (solutions, suspensions, gels, ointments), offered via proprietary R&D and CDMO services.

Farmigea competes in two arenas: as a branded ophthalmic product company against large multinationals (e.g., Novartis/Alcon, AbbVie/Allergan) and niche pharma players, and as a CDMO against other specialized ophthalmic manufacturers and large, diversified contract manufacturing organizations (CMOs). Its differentiation lies in its deep, singular focus on ophthalmic formulations and sterile manufacturing.